Archives

Mission: Launch Miami Hackathon Delivers Record-Clearing Support, Sheriff Engagement, and Practical Next Steps for Improving Reentry Outcomes

B Two-day Bank on 100 Million Miami Hackathon produced early-stage solutions, cross-sector commitments, and next steps to strengthen workforce readiness, record relief, and family-centered reentry… Login to continue reading Login…

Read MoreMission: Launch Miami Hackathon Delivers Record-Clearing Support, Sheriff Engagement, and Practical Next Steps for Improving Reentry Outcomes

T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES MARCH 31, 2026 FINANCIAL RESULTS AND DECLARED TOTAL DISTRIBUTIONS OF $0.69 PER SHARE IN Q1 2026

B NEW YORK, May 7, 2026 /PRNewswire/ — T. Rowe Price OHA Select Private Credit Fund (the “Company” or “OCREDIT”) today reported financial results and… Login to continue reading Login…

Read MoreT. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES MARCH 31, 2026 FINANCIAL RESULTS AND DECLARED TOTAL DISTRIBUTIONS OF $0.69 PER SHARE IN Q1 2026

PMI U.S. Expands Support for Military Families with $260,000 in New Donations During Military Appreciation Month

B New funding strengthens mental health, peer support, and wellness programs; cumulative contributions to Elizabeth Dole Foundation, TAPS, and Veteran Spouse Network reach $810,000 STAMFORD,… Login to continue reading Login…

Read MorePMI U.S. Expands Support for Military Families with $260,000 in New Donations During Military Appreciation Month

Pierre Fabre Pharmaceuticals Announces Regulatory Update Following Type A Meeting with U.S. Food and Drug Administration (FDA) on Tabelecleucel Biologic License Application (BLA)

B SECAUCUS, N.J., May 7, 2026 /PRNewswire/ — Pierre Fabre Pharmaceuticals, Inc. (PFP), announces it has aligned with FDA on a potential path forward for resubmission… Login to continue reading Login…

Read MorePierre Fabre Pharmaceuticals Announces Regulatory Update Following Type A Meeting with U.S. Food and Drug Administration (FDA) on Tabelecleucel Biologic License Application (BLA)